Contact Information: Contact: Daniel Culver FONAR Corporation Tel: 631-694-2929 Fax: 631-390-1709 http://www.fonar.com
Physicians Who Use the FONAR UPRIGHT(TM) MRI Testify to the Unique Benefits in Patient Care; Sales Take Dramatic Upswing
| Source: FONAR Corporation
MELVILLE, NY--(Marketwire - July 12, 2007) - FONAR Corporation (NASDAQ : FONR ), The Inventor
of MR Scanning™, reported today that physicians who use the FONAR
UPRIGHT™ MRI are testifying to the unique benefits of the technology in
patient care. They're appearing in 2-page color advertisements in the
peer-reviewed journal 'Radiology,' published by the Radiologic Society of
North America.
The physicians are introduced with the headline, "Why So Many Surgeons Are
Buying the FONAR UPRIGHT™ MRI." Then they speak for themselves.
The testimonials of the prominent surgeons and leading radiologists are
also appearing in advertisements in numerous other major medical magazines,
including The Journal of the American Medical Association, Spine,
Radiology, Diagnostic Imaging, The Journal of the American Academy of
Orthopedics and the Journal of Neurology.
Their expert testimonies on the medical benefits brought to their patients
of FONAR's UPRIGHT™ technology has resulted in the recent stream of 7
new orders for FONAR's UPRIGHT™ MRI scanners, as FONAR announced on
Tuesday, July 10.
All the surgeons featured are owners of the FONAR UPRIGHT™
Multi-Position™ MRI, so they have hands-on experience with its unique
ability to image pathology in the position of the patient's symptoms.
Their consensus is that the UPRIGHT™ changes their surgical protocols
and improves surgical outcomes in over 20% of their cases.
"The most identifiable causes of failed back surgery include... failure to
identify the structural source(s) of pain correctly." (The Failed Spine,
Lippincott Williams & Wilkins, 2005, p. 124.)
The FONAR UPRIGHT™ Multi-Position™ MRI provides the necessary
technology to image the patient's spine pathology in a full range of
motion. As a result, it gives surgeons the right tool to overcome the
present diagnostic limitations.
To see the testimonials of the these outstanding physicians as printed in
the Journal Radiology and other major medical journals, click on this link:
http://www.fonar.com/news/pdf/radiology_ad_2007.pdf
About FONAR
FONAR has the most accomplished history of any company in MRI. The
company's heritage helps to document the quality of its products and
distinguishes it from all other MRI companies. A timeline of its
achievements follows. It includes the groundbreaking discovery of the
principle that makes MRI imaging possible, the patent for the first MRI,
and the sale of the world's first MRI.
1969
Original Idea for MR Scanner
(Grant Application to Health Research Council of the City of New York)
1969
Realizes Need for a Compelling Application to Justify Building Human
Scanner. Decides on Cancer Detection
1970
Key Discovery Makes the MRI Possible
Discovery of the marked T1 and T2 signal differences among the normal
tissues and also between the normal tissue and cancer tissue. Discovery
enables soft-tissue detail previously absent from medical imaging, and
early cancer detection; used today to detect cancers worldwide. "NMR
developed into a laboratory spectroscopic technique capable of examining
the molecular structure of compounds, until Damadian's ground-breaking
discovery in 1971." MRI From Picture to Proton, Cambridge University Press,
2003)
March 1971
First Article Published (Science)
Spring 1971
First Ever Method Proposed (Downstate Reporter)
March 1972
First MR Patent Filed (3D Serial Voxel Scanning Method). Patent Issued
1974.
1976
The Struggle Begins. Expert Declares, "Any further discussion of scanning
the human body by MR (NMR) is visionary nonsense."
1976
Construction of First Human MR Scanner Commences
1977
Construction Completed; First Human Scan Achieved: Thoracic Image at T-8
1980
FONAR Installs First Commercial MRI; Initiates MRI Industry
1997
Patent Upheld by High Court on U.S. Patents and the U.S. Supreme Court.
(1.1 Million Pages of Documentary Evidence Scrutinized and Argued; No Prior
Art)
2001
Introduction of the FONAR UPRIGHT™ Multi-Position™ MRI.
2007
National Inventor of the Year Award for the FONAR UPRIGHT™
Multi-Position™ MRI.
More about the FONAR UPRIGHT™ Multi-Position™ MRI.
The FONAR UPRIGHT™ Multi-Position™ MRI is a dramatic advance over all
other MRIs, which can only scan the patient in a recumbent-only,
non-weight-bearing position. The UPRIGHT™ allows the patient to be
imaged upright, with the weight of the body on the spine.
Most patients are scanned sitting, while they enjoy watching TV. Patients
can also be scanned in flexion, extension, rotation, as well as lying down.
This positional imaging allows surgeons and radiologists to see patients in
the position of their symptoms. Studies and physician experience show that
diagnosis using the FONAR UPRIGHT™ changes surgical protocols and
provides better surgical outcomes in approximately 20% of the cases.
The FONAR UPRIGHT™ Multi-Position™ MRI is also unrivaled in patient
comfort. It has a near zero claustrophobic rejection rate by patients. It
can scan obese patients who cannot fit into a recumbent MRI, and it allows
imaging of children while they sit in their mother's lap.
Over a half million patients have been scanned by the FONAR UPRIGHT™
MRI.
To date, 152 UPRIGHT™ MRIs have been sold. The superiority of the
technology is achieving wider recognition every day.
ANOTHER NEW FONAR MRI: THE FONAR 360
FONAR has invented another breakthrough MRI, the FONAR 360™. It's a
room-size recumbent scanner that optimizes openness while facilitating
physician access to the patient during surgery.
Visit: www.fonar.com/history.htm
FONAR is headquartered on Long Island, New York, and has approximately 400
employees.
The Inventor of MR Scanning™, Full Range of Motion™, STAND-UP™,
UPRIGHT™, pMRI™, Multi-Position™, True Flow™, and The Proof is
in the Picture™ are trademarks of FONAR Corporation.
Be sure to visit FONAR's Website for product and investor information:
www.fonar.com
This release may include forward-looking statements from the company that
may or may not materialize. Additional information on factors that could
potentially affect the company's financial results may be found in the
company filings with the Securities and Exchange Commission.